


Healthcare News Roundup: Personnel
HSMN NewsFeed - 22 May 2018
AbelsonTaylor Hires Amanda Hartzmark as Director of Business Development and Analysis
AbelsonTaylor Hires Amanda Hartzmark as Director of Business Development and Analysis
HSMN NewsFeed - 14 May 2018
GT Biopharma Announces Dr. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company
GT Biopharma Announces Dr. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company
HSMN NewsFeed - 14 May 2018
Accomplished Global Pharmaceutical Executive, Federico Seghi Recli, Appointed To Titan's Board
Accomplished Global Pharmaceutical Executive, Federico Seghi Recli, Appointed To Titan's Board
HSMN NewsFeed - 10 May 2018
Aldeyra Therapeutics Appoints David McMullin as Senior Vice President, Corporate Development and Strategy
Aldeyra Therapeutics Appoints David McMullin as Senior Vice President, Corporate Development and Strategy
HSMN NewsFeed - 8 May 2018
Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
HSMN NewsFeed - 8 May 2018
Pliant Therapeutics Appoints Hoyoung Huh as Chairman and Éric Lefebvre as Chief Medical Officer
Pliant Therapeutics Appoints Hoyoung Huh as Chairman and Éric Lefebvre as Chief Medical Officer
HSMN NewsFeed - 8 May 2018
TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
HSMN NewsFeed - 3 May 2018
CytRx Corporation Names Eric L. Curtis as Its President and Chief Operating Officer
CytRx Corporation Names Eric L. Curtis as Its President and Chief Operating Officer
HSMN NewsFeed - 3 May 2018
GigaGen Announces Appointment of Sheila M. Keating, Ph.D., as Director, Immunology
GigaGen Announces Appointment of Sheila M. Keating, Ph.D., as Director, Immunology
HSMN NewsFeed - 1 May 2018
Pharmaceutical Business Development Leader Dr. Kevin Lynch Joins Recursion as Chief Business Officer
Pharmaceutical Business Development Leader Dr. Kevin Lynch Joins Recursion as Chief Business Officer
HSMN NewsFeed - 30 Apr 2018
Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough
Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough
HSMN NewsFeed - 30 Apr 2018
Adicet Bio appoints Elizabeth "EJ" Read, M.D. as Chief Technology Officer
Adicet Bio appoints Elizabeth "EJ" Read, M.D. as Chief Technology Officer
HSMN NewsFeed - 27 Apr 2018
Hill-Rom Appoints John Groetelaars As President And Chief Executive Officer
Hill-Rom Appoints John Groetelaars As President And Chief Executive Officer
HSMN NewsFeed - 26 Apr 2018
Seasoned Financial Executive Federica O'Brien Joins GT Biopharma's Board of Directors
Seasoned Financial Executive Federica O'Brien Joins GT Biopharma's Board of Directors
HSMN NewsFeed - 25 Apr 2018
Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego
Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego
HSMN NewsFeed - 24 Apr 2018
Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors
Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors
HSMN NewsFeed - 23 Apr 2018
OrphoMed Appoints Gary M. Phillips, M.D. as President and Chief Executive Officer
OrphoMed Appoints Gary M. Phillips, M.D. as President and Chief Executive Officer
HSMN NewsFeed - 20 Apr 2018
SELLAS Life Sciences Announces Appointment of Gene Mack as Chief Financial Officer & Treasurer
SELLAS Life Sciences Announces Appointment of Gene Mack as Chief Financial Officer & Treasurer
HSMN NewsFeed - 20 Apr 2018
Lannett Names Maureen Cavanaugh Senior Vice President And Chief Commercial Operations Officer
Lannett Names Maureen Cavanaugh Senior Vice President And Chief Commercial Operations Officer
HSMN NewsFeed - 13 Apr 2018
Cellenkos, Inc. Announces Alick Sun as Senior Vice President for Corporate and Business Development
Cellenkos, Inc. Announces Alick Sun as Senior Vice President for Corporate and Business Development
HSMN NewsFeed - 12 Apr 2018
CollPlant Appoints Revital Mandil-Levin as Chief Business Development Officer
CollPlant Appoints Revital Mandil-Levin as Chief Business Development Officer
HSMN NewsFeed - 12 Apr 2018
Conventus Orthopaedics Appoints Jonathan Isenburg as Chief Financial Officer
Conventus Orthopaedics Appoints Jonathan Isenburg as Chief Financial Officer
HSMN NewsFeed - 11 Apr 2018
Genprex Appoints Julien Pham, MD, MPH As President To Lead Commercialization Of Oncoprex Immunogene Therapy
Genprex Appoints Julien Pham, MD, MPH As President To Lead Commercialization Of Oncoprex Immunogene Therapy
HSMN NewsFeed - 10 Apr 2018
TCR2 Therapeutics Appoints Leading Biotech Analyst Ian Somaiya as Chief Financial Officer
TCR2 Therapeutics Appoints Leading Biotech Analyst Ian Somaiya as Chief Financial Officer
HSMN NewsFeed - 5 Apr 2018
Former Acelity, J&J Executive Joins Organogenesis as Vice President of Global Medical & Clinical Affairs
Former Acelity, J&J Executive Joins Organogenesis as Vice President of Global Medical & Clinical Affairs
HSMN NewsFeed - 4 Apr 2018
Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
HSMN NewsFeed - 4 Apr 2018
Angus Russell to Succeed Melvin Booth as Mallinckrodt Chairman of the Board in May 2018
Angus Russell to Succeed Melvin Booth as Mallinckrodt Chairman of the Board in May 2018
HSMN NewsFeed - 4 Apr 2018
Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors
Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors
HSMN NewsFeed - 3 Apr 2018
Oncternal Therapeutics Further Strengthens Leadership with Additions to Board of Directors
Oncternal Therapeutics Further Strengthens Leadership with Additions to Board of Directors
HSMN NewsFeed - 3 Apr 2018
Bridge Medicines Appoints Louis M. Renzetti, Ph.D., As Chief Scientific Officer
Bridge Medicines Appoints Louis M. Renzetti, Ph.D., As Chief Scientific Officer
HSMN NewsFeed - 3 Apr 2018
Kleo Pharmaceuticals Inc. Appoints Luca Rastelli, PhD as Chief Scientific Officer
Kleo Pharmaceuticals Inc. Appoints Luca Rastelli, PhD as Chief Scientific Officer
HSMN NewsFeed - 2 Apr 2018
Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer
Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer
HSMN NewsFeed - 2 Apr 2018
Halyard Health, Inc. Appoints Sarker as Senior Vice President, International
Halyard Health, Inc. Appoints Sarker as Senior Vice President, International
